← Back
Data updated: Mar 29, 2026
MEM SLOAN-KETTERING
CardiovascularMetabolicOphthalmology
Generics
MEM SLOAN-KETTERING is a generic drug manufacturer focused on Cardiovascular, Metabolic, Ophthalmology.
2016
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 49%
0 drugs Phase 3: 10 Phase 2: 1
Metabolic 38%
0 drugs Phase 3: 8
Ophthalmology 7%
0 drugs Phase 3: 1 Phase 2: 1
Dermatology 5%
0 drugs Phase 3: 1
Infectious Disease 1%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Metabolic, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology, Dermatology, Metabolic
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2016-12-08
- Latest
- 2016-12-08
- Applications
- 1